Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET)

Boston Scientific Registry of Deep Brain Stimulations for Treatment of Essential Tremor (ET):ET Registry

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04032470

Enrollment

500

Registered

2019-07-25

Start date

2019-10-23

Completion date

2029-12-01

Last updated

2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Essential Tremor

Keywords

Deep Brain Stimulation, Boston Scientific, Essential Tremor

Brief summary

To compile characteristics of real-world outcomes for Boston Scientific Corporation's commercially approved Deep Brain Stimulation (DBS) Systems, when used according to the applicable Directions for Use, for the treatment of Essential Tremor.

Detailed description

To compile characteristics of real-world outcomes using Deep Brain Stimulation (DBS) for the treatment of Essential Tremor to add to the evidence available for treatment of ET.

Interventions

DEVICEDeep Brain Stimulation Systems (DBS)

Subjects receiving DBS implant for treatment of Essential Tremor

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Meets criteria established in the locally applicable Directions for Use (DFU) for Essential Tremor * Is at least 18 years old

Exclusion criteria

* Meets any contraindication in locally applicable Directions for Use

Design outcomes

Primary

Measure	Time frame	Description
Change in Quality of Life during the study as compared with baseline using the Quality of Life in Essential Tremor Questionnaire (QUEST)	Up to 3 years	Change in quality of life over the course of the study using QUEST

Countries

Austria, Belgium, Canada, Germany, Hungary, Italy, Portugal, South Korea, Spain

Contacts

CONTACTStephanie Delvaux

BSNClinicalTrials@bsci.com855-213-9890

CONTACTDiane Keesey

BSNClinicalTrials@bsci.com855-213-9890

STUDY_DIRECTORNatalie Bloom Lyons

Boston Scientific Corporation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026